Larry Lynd

Dr. Lynd is a Professor and Dean of the Faculty of Pharmaceutical Sciences at UBC and the Director of the Collaboration for Outcomes Research and Evaluation. He is a scientist at the Centre for Clinical Epidemiology and Evaluation; scientist at the Centre for Advancing Health Outcomes (formerly CHÉOS); scholar at the Peter Wall Institute of Advanced Studies; and associate of the UBC School of Population and Public Health. His role in PROGENITER will be at later stages of the project where it will be important to ensure that the therapeutic antibodies we develop have the most societal relevance and address affected populations equitably.